INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$785K

$785,427

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-11-17 $272,739 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-11-17	$272,739	S	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-10-17 $266,654 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-10-17	$266,654	S	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-09-26 $74,228 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-09-26	$74,228	S	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-09-23 $56,084 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-09-23	$56,084	S	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-09-19 $20,250 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-09-19	$20,250	S	Form 4
ELVN S Enliven Therapeutics, Inc. Kintz Samuel • CEO 10b5-1 Sell 2025-09-17 $95,473 View Form 4 →
ELVN	Enliven Therapeutics, Inc.	Kintz Samuel CEO 10b5-1 Sell	2025-09-17	$95,473	S	Form 4